Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Soy Protein Isolate Suppresses Bone Resorption and Improves Trabecular Microarchitecture in Spontaneously Hyperphagic, Rapidly Growing Male OLETF Rats.

Dirkes RK, Richard MW, Meers GM, Butteiger DN, Krul ES, Thyfault JP, Rector RS, Hinton PS.

Curr Dev Nutr. 2018 Apr 17;2(4):nzy010. doi: 10.1093/cdn/nzy010. eCollection 2018 Apr.

2.

Chronic dietary supplementation with soy protein improves muscle function in rats.

Khairallah RJ, O'Shea KM, Ward CW, Butteiger DN, Mukherjea R, Krul ES.

PLoS One. 2017 Dec 7;12(12):e0189246. doi: 10.1371/journal.pone.0189246. eCollection 2017.

3.

Effects of isoflavone-containing soya protein on ex vivo cholesterol efflux, vascular function and blood markers of CVD risk in adults with moderately elevated blood pressure: a dose-response randomised controlled trial.

Richter CK, Skulas-Ray AC, Fleming JA, Link CJ, Mukherjea R, Krul ES, Kris-Etherton PM.

Br J Nutr. 2017 May;117(10):1403-1413. doi: 10.1017/S000711451700143X.

4.

Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats.

Panasevich MR, Schuster CM, Phillips KE, Meers GM, Chintapalli SV, Wankhade UD, Shankar K, Butteiger DN, Krul ES, Thyfault JP, Rector RS.

J Nutr Biochem. 2017 Aug;46:125-136. doi: 10.1016/j.jnutbio.2017.05.004. Epub 2017 May 31.

5.

Muscle Protein Signaling in C2C12 Cells Is Stimulated to Similar Degrees by Diverse Commercial Food Protein Sources and Experimental Soy Protein Hydrolysates.

Roeseler DA, McGraw NJ, Butteiger DN, Shah N, Hall-Porter J, Mukherjea R, Krul ES.

J Agric Food Chem. 2017 Apr 12;65(14):2956-2964. doi: 10.1021/acs.jafc.6b05460. Epub 2017 Mar 31.

PMID:
28339214
6.

Soy-based renoprotection.

McGraw NJ, Krul ES, Grunz-Borgmann E, Parrish AR.

World J Nephrol. 2016 May 6;5(3):233-57. doi: 10.5527/wjn.v5.i3.233. Review.

7.

Soy Protein Compared with Milk Protein in a Western Diet Increases Gut Microbial Diversity and Reduces Serum Lipids in Golden Syrian Hamsters.

Butteiger DN, Hibberd AA, McGraw NJ, Napawan N, Hall-Porter JM, Krul ES.

J Nutr. 2016 Apr;146(4):697-705. doi: 10.3945/jn.115.224196. Epub 2016 Mar 2.

PMID:
26936141
8.
9.

Partially hydrolyzed soy protein shows enhanced transport of amino acids compared to nonhydrolyzed protein across an intestinal epithelial cell monolayer.

McGraw NJ, Napawan N, Toland MR, Schulze J, Tulk BM, Krul ES.

J Food Sci. 2014 Sep;79(9):H1832-40. doi: 10.1111/1750-3841.12553. Epub 2014 Jul 17.

PMID:
25040304
10.

Effect of a 6-month vegan low-carbohydrate ('Eco-Atkins') diet on cardiovascular risk factors and body weight in hyperlipidaemic adults: a randomised controlled trial.

Jenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, Faulkner DA, Vidgen E, Paul G, Mukherjea R, Krul ES, Singer W.

BMJ Open. 2014 Feb 5;4(2):e003505. doi: 10.1136/bmjopen-2013-003505.

11.

Effect of stearidonic acid-enriched soybean oil on fatty acid profile and metabolic parameters in lean and obese Zucker rats.

Casey JM, Banz WJ, Krul ES, Butteiger DN, Goldstein DA, Davis JE.

Lipids Health Dis. 2013 Oct 19;12:147. doi: 10.1186/1476-511X-12-147.

12.

Consumption of stearidonic acid-rich oil in foods increases red blood cell eicosapentaenoic acid.

Lemke SL, Maki KC, Hughes G, Taylor ML, Krul ES, Goldstein DA, Su H, Rains TM, Mukherjea R.

J Acad Nutr Diet. 2013 Aug;113(8):1044-56. doi: 10.1016/j.jand.2013.04.020.

PMID:
23885702
13.

A soy, whey and caseinate blend extends postprandial skeletal muscle protein synthesis in rats.

Butteiger DN, Cope M, Liu P, Mukherjea R, Volpi E, Rasmussen BB, Krul ES.

Clin Nutr. 2013 Aug;32(4):585-91. doi: 10.1016/j.clnu.2012.10.001. Epub 2012 Oct 13.

14.

Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content.

Krul ES, Lemke SL, Mukherjea R, Taylor ML, Goldstein DA, Su H, Liu P, Lawless A, Harris WS, Maki KC.

Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):51-9. doi: 10.1016/j.plefa.2011.10.005. Epub 2011 Nov 6.

PMID:
22064208
15.

Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia.

Maki KC, Butteiger DN, Rains TM, Lawless A, Reeves MS, Schasteen C, Krul ES.

J Clin Lipidol. 2010 Nov-Dec;4(6):531-42. doi: 10.1016/j.jacl.2010.09.001. Epub 2010 Oct 1.

PMID:
21122701
16.

Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety.

Lemke SL, Vicini JL, Su H, Goldstein DA, Nemeth MA, Krul ES, Harris WS.

Am J Clin Nutr. 2010 Oct;92(4):766-75. doi: 10.3945/ajcn.2009.29072. Epub 2010 Aug 25.

PMID:
20739419
17.

Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.

Braun A, Yesilaltay A, Acton S, Broschat KO, Krul ES, Napawan N, Stagliano N, Krieger M.

Atherosclerosis. 2008 May;198(1):77-84. Epub 2007 Dec 3.

18.

Using genetic variation to optimize nutritional preemption.

Gillies PJ, Krul ES.

J Nutr. 2007 Jan;137(1 Suppl):270S-274S. doi: 10.1093/jn/137.1.270S.

PMID:
17182839
19.

Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.

Telford DE, Edwards JY, Lipson SM, Sutherland B, Barrett PH, Burnett JR, Krul ES, Keller BT, Huff MW.

J Lipid Res. 2003 May;44(5):943-52. Epub 2003 Feb 1.

20.

Chiral N,N-disubstituted trifluoro-3-amino-2-propanols are potent inhibitors of cholesteryl ester transfer protein.

Durley RC, Grapperhaus ML, Hickory BS, Massa MA, Wang JL, Spangler DP, Mischke DA, Parnas BL, Fobian YM, Rath NP, Honda DD, Zeng M, Connolly DT, Heuvelman DM, Witherbee BJ, Melton MA, Glenn KC, Krul ES, Smith ME, Sikorski JA.

J Med Chem. 2002 Aug 29;45(18):3891-904.

PMID:
12190312
21.

Effect of exercise and medium-chain fatty acids on postprandial lipemia.

Thomas TR, Horner KE, Langdon MM, Zhang JQ, Krul ES, Sun GY, Cox RH.

J Appl Physiol (1985). 2001 Apr;90(4):1239-46.

22.

Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein.

Durley RC, Grapperhaus ML, Massa MA, Mischke DA, Parnas BL, Fobian YM, Rath NP, Honda DD, Zeng M, Connolly DT, Heuvelman DM, Witherbee BJ, Glenn KC, Krul ES, Smith ME, Sikorski JA.

J Med Chem. 2000 Nov 30;43(24):4575-8. No abstract available.

PMID:
11101348
23.

Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms.

Srivastava RA, Krul ES, Lin RC, Schonfeld G.

Mol Cell Biochem. 1997 Aug;173(1-2):161-8.

PMID:
9278267
24.

Inhibition of cholesteryl ester transfer protein by apolipoproteins, lipopolysaccharides, and cholesteryl sulfate.

Connolly DT, Krul ES, Heuvelman D, Glenn KC.

Biochim Biophys Acta. 1996 Nov 22;1304(2):145-60.

PMID:
8954138
25.

Physical and kinetic characterization of recombinant human cholesteryl ester transfer protein.

Connolly DT, McIntyre J, Heuvelman D, Remsen EE, McKinnie RE, Vu L, Melton M, Monsell R, Krul ES, Glenn K.

Biochem J. 1996 Nov 15;320 ( Pt 1):39-47.

26.

Quantitation of apolipoprotein E.

Krul ES, Cole TG.

Methods Enzymol. 1996;263:170-87.

PMID:
8749007
27.

Identification and characterization of truncated forms of apolipoprotein B in hypobetalipoproteinemia.

Young SG, Krul ES, McCormick S, Farese RV Jr, Linton MF.

Methods Enzymol. 1996;263:120-45. No abstract available.

PMID:
8749004
28.

Familial hypobetalipoproteinemia is not associated with low levels of lipoprotein(a).

Averna M, Marcovina SM, Noto D, Cole TG, Krul ES, Schonfeld G.

Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2165-75.

PMID:
7489238
29.

Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2).

Groenewegen WA, Krul ES, Averna MR, Pulai J, Schonfeld G.

Arterioscler Thromb. 1994 Nov;14(11):1695-704.

PMID:
7947592
30.

Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL.

Groenewegen WA, Averna MR, Pulai J, Krul ES, Schonfeld G.

J Lipid Res. 1994 Jun;35(6):1012-25.

31.

Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia.

Talmud PJ, Krul ES, Pessah M, Gay G, Schonfeld G, Humphries SE, Infante R.

J Lipid Res. 1994 Mar;35(3):468-77.

32.
34.

Lengths of truncated forms of apolipoprotein B (apoB) determine their intestinal production.

Krul ES, Tang J, Kettler TS, Clouse RE, Schonfeld G.

Biochem Biophys Res Commun. 1992 Dec 15;189(2):1069-76.

PMID:
1472017
35.

Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells.

Wagner RD, Krul ES, Moberly JB, Alpers DH, Schonfeld G.

Am J Physiol. 1992 Aug;263(2 Pt 1):E374-82.

PMID:
1514621
36.

ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies.

Krul ES, Parhofer KG, Barrett PH, Wagner RD, Schonfeld G.

J Lipid Res. 1992 Jul;33(7):1037-50.

37.

Secretion of apolipoprotein E by an astrocytoma cell line.

Krul ES, Tang J.

J Neurosci Res. 1992 Jun;32(2):227-38.

PMID:
1404494
38.

Dietary fatty acids and dietary cholesterol differ in their effect on the in vivo regulation of apolipoprotein A-I and A-II gene expression in inbred strains of mice.

Srivastava RA, Tang J, Krul ES, Pfleger B, Kitchens RT, Schonfeld G.

Biochim Biophys Acta. 1992 May 8;1125(3):251-61.

PMID:
1596514
40.
41.

In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice.

Tang JJ, Srivastava RA, Krul ES, Baumann D, Pfleger BA, Kitchens RT, Schonfeld G.

J Lipid Res. 1991 Oct;32(10):1571-85.

42.

ApoB-54.8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the apoB gene and hypobetalipoproteinemia.

Wagner RD, Krul ES, Tang J, Parhofer KG, Garlock K, Talmud P, Schonfeld G.

J Lipid Res. 1991 Jun;32(6):1001-11.

43.

Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins.

Jonas A, Wald JH, Toohill KL, Krul ES, K├ęzdy KE.

J Biol Chem. 1990 Dec 25;265(36):22123-9.

44.
46.

Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation.

Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG.

Hepatology. 1990 Jan;11(1):59-64. Review.

PMID:
2403963
47.

Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia.

Krul ES, Kinoshita M, Talmud P, Humphries SE, Turner S, Goldberg AC, Cook K, Boerwinkle E, Schonfeld G.

Arteriosclerosis. 1989 Nov-Dec;9(6):856-68.

PMID:
2574033
48.
49.

Regional specificities of monoclonal anti-human apolipoprotein B antibodies.

Krul ES, Kleinman Y, Kinoshita M, Pfleger B, Oida K, Law A, Scott J, Pease R, Schonfeld G.

J Lipid Res. 1988 Jul;29(7):937-47.

50.

Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells.

Kleinman Y, Krul ES, Burnes M, Aronson W, Pfleger B, Schonfeld G.

J Lipid Res. 1988 Jun;29(6):729-43.

Supplemental Content

Support Center